Dear
Colleague:
The 8th HIC/RPC
Bioseparation Conference will be highlighted by two keynote addresses.
They, along with presentations of the latest work coming from the
top labs in academia and industry, promise to make this a first
class conference. The keynote speakers will discuss the state of
the art developments in our understanding of the effects of water
on the critical challenge of creating selectivity in process chromatographic
systems. The keynote titles and presenters are:
- “Water:
why the sudden interest in its use for reversed phase, hydrophobic
interaction, and mixed-mode bioseparations” to
be given by Professor Milton Hearn, Monash University
- “Water,
proteins, and interfaces: a new molecular perspective”
to be given by Professor Shekhar Garde, RPI
Registration
details for the Conference can be found at the 8th HIC/RPC Bioseparation
Conference website.
Please
note that the abstract submission deadline of Oct. 19, 2012 is rapidly
approaching. Abstracts on the following topics are
still being accepted:
- Industrial
Case Studies in HIC, RPC and Multimodal Purifications
- Fundamentals
of HIC/RPC/Multimodal Chromatography
- Novel Stationary
Phases
- New Engineering
Approaches for Downstream Bioprocessing
- Protein
Structure, Interactions and Stability
- Antibody
Conjugates: Challenges for Bioprocessing
- High Throughput
Methodologies
- Biosimilars
- Quality
by Design/ Regulatory Aspects
To submit your
abstract, please complete this form.
We look forward
to your participation in the conference.
Best regards,

Steven M. Cramer, Ph.D.
Scientific Committee Chair
8th HIC-RPC Bioseparation Conference |
Scientific
Committee Chair
Prof.
Steven M. Cramer
Rensselaer Polytechnic Institute
Scientific Committee
Tim
Breece
Xoma Ltd.
Jie
Chen
DYAX CORP
Klaus
Graumann
Sandoz GmbH
Professor
Milton T. W. Hearn
Monash University
Prof.
Alois Jungbauer
University of Natural Resources and Applied Life Sciences
Wolfgang
Kuhne
Roche Diagnostics GmbH
Egbert
Müller
Tosoh Bioscience GmbH
Arne
Staby
Novo Nordisk A/S
Rick
St. John
Genentech Inc |
|